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The molecular pathways controlling cerebellar Pur-
kinje cell dendrite formation and maturation are
poorly understood. The Purkinje cell degeneration
(pcd) mutant mouse is characterized by mutations
in Nna1, a gene discovered in an axonal regenerative
context, but whose actual function in development
and disease is unknown. We found abnormal devel-
opment of Purkinje cell dendrites in postnatal pcdSid
mice and linked this deficit to a deletion mutation in
exon 7 of Nna1. With single cell gene profiling and
virus-based gene transfer, we analyzed a molecular
pathway downstream to Nna1 underlying abnormal
Purkinje cell dendritogenesis in pcdSid mice. We
discovered that mutant Nna1 dramatically increases
intranuclear localization of lysyl oxidase propeptide,
which interferes with NF-kB RelA signaling and
microtubule-associated protein regulation of micro-
tubule stability, leading to underdevelopment of
Purkinje cell dendrites. These findings provide
insight into Nna1’s role in neuronal development
and why its absence renders Purkinje cells more
vulnerable.
INTRODUCTION
Cerebellar Purkinje cells are central neurons controlling motor
learning and coordination. Many fundamental concepts of
modern neuroscience have been established by a focus on these
vividly constructed cells (Rossi and Tempia, 2006). Three unique
features make Purkinje cells a valuable model for the discovery
of mechanisms underlying neuronal development and degener-
ation. First, Purkinje cells develop postnatally the most elaboratedendritic trees of all neurons in the human and rodent brain
(Kapfhammer, 2004). Second, Purkinje cells are the most vulner-
able neurons in various neurological diseases ranging from
genetic defects to acquired injury or poisoning and from autism
to Alzheimer’s (Sarna and Hawkes, 2003). Third, Purkinje cells
often undergo dendritic malfunction and cell death in circum-
stances that may cause lesser, but still debilitating, damage in
other areas of the brain (Sirzen-Zelenskaya et al., 2006).
Because dendritogenesis is a key process in Purkinje cell
development, essential for establishment of cerebellar circuitry,
it is important to determine how developing Purkinje cell
dendrites acquire their characteristic size and morphology
(Wong and Ghosh, 2002). Development of Purkinje cell dendrites
in postnatal cerebellum can be divided into two successive,
tightly regulated stages. In the first postnatal week, bipolar
fusiform Purkinje cells retract their primitive processes and
extend numerous short perisomatic protrusions. In the second
and third postnatal weeks, Purkinje cells form a primary dendrite
and undergo rapid dendritic elongation and branching in the
sagittal plane to elaborate their typical dendritic tree (Sotelo
and Dusart, 2009). Although a number of genetic and environ-
mental factors relate to cytoskeletal organization in Purkinje cells
(Shima et al., 2004), the molecular pathways controlling dendrite
formation and maturation, in contrast to axonogenesis, are
poorly understood (Poulain et al., 2008). Purkinje cell dendrites
are also abnormal in many diseases by mechanisms yet to be
elucidated (Becker et al., 2009).
Here we characterized the Purkinje cell degeneration (pcd)
mutant, pcdSid and uncovered an exon 7 deletion in Nna1
(neuronal nuclear protein induced by axotomy). We then identi-
fied upregulated lysyl oxidase (Lox) as a candidate molecule
for dendritic underdevelopment of young pcdSid Purkinje cells.
Lox is an extracellular copper enzyme that catalyzes conversion
of lysine residues to aldehydes in collagen and elastin precur-
sors, contributing to extracellular matrix formation and repair
(Lucero and Kagan, 2006). Lox also plays diverse roles in
developmental regulation of cardiovascular, pulmonary andNeuron 68, 45–60, October 7, 2010 ª2010 Elsevier Inc. 45
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Figure 1. Characterization of Cerebellar Histopathology, Motor Ability, and Nna1 Mutation in pcdSid Mutant Mice
(A) Compared to wild-type (wt) mouse, adult P120 pcdSid mutant was smaller and showed motor incoordination.
(B) Hematoxylin and eosin (H&E)-stained sagittal section showed an atrophic cerebellum in P120 pcdSid mutant. Scale bar represents 500 mm.
(C) Neuron-specific nuclear protein (NeuN)-stained granule cells (red) in the granular layer (GL) were slightly decreased, whereas the molecular layer (ML) was
obviously reduced in P120 pcdSid cerebellar cortex. DAPI stained cell nuclei (blue). Scale bar represents 50 mm.
(D) Calbindin (Calb)-stained Purkinje cells (red) were totally lost in P60 pcdSid cerebellar cortex. Scale bar represents 50 mm.
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Control of PC Dendrite Genesis by Lox and RelAcutaneous systems; and Lox-deficient mice die perinatally
(Ma¨ki, 2009). Although Lox increases in injured rat brain (Gilad
et al., 2001), mutant SOD1 transgenic mouse brain (Li et al.,
2004) and Alzheimer’s disease human brain (Gilad et al., 2005),
its modes of action in the central nervous system (CNS) are
almost unknown.
With a set of complementary approaches, including primary
Purkinje cell and organotypic slice cultures, neonatal cerebellar
cortex injection, lentiviral vector-based cDNA or shRNA trans-
duction, enzyme dynamics and dendritic tree quantification,
we defined a molecular pathway leading to the dendritic under-
development. In this pathway, the Nna1 mutation increases
localization of Lox propeptide (a Lox fragment without enzymatic
activity) in Purkinje cell nuclei, followed by inhibition of NF-kB
RelA signaling, which further decreases microtubule-associated
protein (MAP) 1B andMAP2, eventually suppressing Purkinje cell
dendritic growth. NF-kB and MAPs were reported to regulate
neuronal process outgrowth and migration (Gutierrez et al.,
2005; Teng et al., 2001), and we further dissected their roles
in postnatal development of Purkinje cell dendrites. This Lox-
based metabolic pathway affects dendritogenesis, without an
apparent effect on Purkinje cell viability.
RESULTS
Characterization of the Nna1Mutation and Purkinje Cell
Pathogenesis in pcdSid Mutant Mice
A spontaneous mutation was discovered in two mice in a litter of
presumed wild-type BALB/c mice purchased from Charles River
Laboratories. Ataxic progeny appeared in crosses of unaffected
siblings with pcd1J mice, and further breeding and histopatho-
logical analyses established that the mutation was allelic with
pcd. It was named according to standard nomenclature proce-
dures as pcdSid and has been maintained congenic with the
C57BL/6J strain for more than 25 generations.
Homozygous pcdSid mutants showed reduced width of the
cerebellar molecular layer and death of most Purkinje cells
(Figures 1A–1I), resulting in severe ataxia, as in the previously
described mutant alleles, pcd2J-4J (see Figures S1A–S1F avail-
able online) (Wang and Morgan, 2007). In pcdSid cerebella, all
Purkinje cells were lost in lobules I–VIII between postnatal days
21 (P21) and P30, whereas some Purkinje cells in lobules IX–X
survived for additional weeks. Unequivocal identification of(E) The Purkinje cell body layer (PL) disappeared, and the ML was shrunk in P60
(F) Parvalbumin (Parv)-stained interneurons (red) in the ML showed no obvious ch
pcdSid cerebellar cortex. Scale bar represents 50 mm.
(G) Glial fibrillary acidic protein (GFAP)-stained astrocytes (green) were obviously
represents 50 mm.
(H) Quantification of Purkinje cells in P20 and P40 mouse cerebella. Values repre
(I) Quantification of rotorod test showing motor ability of P40 and P120 mice. n =
(J) RT-PCR detection of Nna1 cDNA from P120 wt and pcdSid cerebra and cere
covering all 23 exons in mouse Nna1 cDNA. Band 1 contained exons 1–8, and
that region. Because band 2 represented exons 7–11, its disappearance in pcdS
(K) cDNA sequencing disclosed a deletion of the entire exon 7 (209 bp), producing
cerebellum.
(L) P14 pcdSid Purkinje cells contained a polyribosome mass in the basal region
(M) Some P20 pcdSid Purkinje cells started to display dark type of apoptotic de
represents 10 mm.pcdSid as an allele at the Nna1 locus came from our evidence
of anNna1 exon 7 deletion in cerebrum and cerebellum of pcdSid
mutants, producing a stop codon in exon 8 (Figures 1J and 1K;
Table S1). In addition, we characterized a six-nucleotide
insertion between exons 6 and 7 of Nna1 in pcd4J brains (Fig-
ures S1G and S1H), in which a lysine at amino acid 176 was
replaced by an isoleucine-lysine-glutamic acid tripeptide.
Affected progeny also appeared in crosses between pcd3J and
pcd4J heterozygotes.
To dissect the pathological process, we examined young
pcdSid Purkinje cells before the onset of neuronal death and
ataxia. In matings of pcdSid heterozygotes, P14 homozygous
pcdSid progeny were distinguished from their heterozygous
and wild-type littermates by accumulation of basal polyribo-
somes in Purkinje cell bodies (Figure 1L), suggesting early abnor-
malities in protein synthesis and processing (Landis and Mullen,
1978). In P20 pcdSid cerebellum, many Purkinje cells exhibited
fewer dendritic branchlets in the molecular layer (Figure 2F),
while some already showed the nuclear condensation and
cytoplasmic shrinkage typical of apoptotic cell death
(Figure 1M) (Dusart et al., 2006). These findings suggest that
the Nna1 mutation in pcdSid may affect downstream molecules
involved in at least three major functions: protein metabolism,
dendritic growth, and apoptosis.
Identification of Molecules Downstream
from Mutant Nna1 in pcdSid Purkinje Cells
The pcd disorder was recognized as Purkinje cell-autonomous
by analysis of wild-type/pcd chimeras (Mullen, 1977), but
available gene expression data in pcd mutants are neither
comprehensive (Kyuhou et al., 2006) nor specific for affected
Purkinje cells (Ford et al., 2008). Therefore, with laser capture
microdissection (LCM) plus Affymetrix GeneChip array (microar-
ray), we measured global gene expression in LCM-isolated
individual Purkinje cell bodies and in LCM-isolated small groups
of granule cells (Figures S2A–S2C and Table S2) from P20 pcdSid
mutant and wild-type littermate cerebella. At this age, the path-
ological process had already begun, but most imperiled pcdSid
Purkinje cells were still surviving.
We focused on candidate molecules whose expressions
changed intensively in pcdSid Purkinje cells compared to wild-
type Purkinje or granule cells and to pcdSid granule cells
(Figure 2A). As verified by quantitative real-time PCR (qPCR)pcdSid cerebellar cortex. Scale bar represents 25 mm.
anges, whereas Parv-stained Purkinje cell bodies at the PL disappeared in P60
increased in the white matter (WM) of P120 pcdSid cerebellar cortex. Scale bar
sented means ± SD; n = 6–8; compared to wild-type control: **p < 0.01.
4–5.
bella. Bands 1–5 represented five fragments amplified by five pairs of primers
its smaller molecular weight in pcdSid samples indicated a partial deletion in
id samples suggested a possible mutation in exon 7 and/or exon 11.
a new stop codon (TGA) in exon 8 of Nna1 cDNA in P120 pcdSid cerebrum and
(arrowheads). Nissl, Nissl staining. Scale bar represents 10 mm.
ath with nuclear condensation and cytoplasmic shrinkage (arrows). Scale bar
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Figure 2. Candidate Molecules Identified by LCM, Microarray, qPCR, and Protein Assays for Pathological Process in Young pcdSid Purkinje
Cells
(A) Microarray analysis showed several upregulated (left) or downregulated (right) genes in P20 LCM-isolated pcdSid PC, compared to wt PC and pcdSid GC.
pcdSid PC and pcdSid GC were from same mouse, and wild-type (wt) cells and pcdSid cells were from littermates.
(B) qPCR verified the microarray results in (A). Gapdh served as an internal control.
(C) Microarray analysis disclosed remarkable upregulation of Calr3, Lox, and Bim in P20 pcdSid PC, compared to wt PC and pcdSid GC.
(D) qPCR verified the microarray results for Calr3, Lox, and Bim.
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candidate molecules, Calr3 (calreticulin 3), Lox, and Bim (Bcl2-
like 11), to be dramatically upregulated >50-fold (Figures 2C
and 2D). Because Calr3 is a molecular chaperone involved in
protein synthesis and processing (Bedard et al., 2005), and
Bim functions as a neuronal apoptosis facilitator (Greene et al.,
2007), the upregulation of Calr3 and Bim expression may be
responsible, respectively, for abnormal protein metabolism
(Figure 1L) and neuronal death (Figure 1M) in young pcdSid
mutants, leading to Purkinje cell death (Figure 2G). Thus, in the
present study, we have addressed a probable role of excess
Lox in regulating postnatal growth of Purkinje cell dendrites.
By measuring spatial and temporal expression of Lox with
qPCR, we found Lox mRNA levels (over the base line at 2% of
Gapdh) to be detectable in most areas of wild-type mouse
embryonic CNS, in 50% of the sampled areas of P7 CNS,
and in fewer areas of adult CNS (Figure S2D), suggesting that
Lox expression decreases with CNS development and matura-
tion. With western blot and immunohistochemistry, we also
found Lox protein levels to be relatively low in P7-P20 wild-
type cerebella, but increased in P20 pcdSid cerebella (Figure 2E)
and Purkinje cells (Figure 2F), concurrent with the reduced
dendritic branching (Figure 2F). Importantly, the above changes
were also found in pcd2J mutants (Figures S1I–S1K).
Suppression of Purkinje Cell Dendritic Growth In Vitro
by Nna1 shRNA or Lox cDNA
We set up mixed cultures of primary cerebellar cells from P0
mouse pups (Figure S3A), in which cultured Purkinje cells
came to resemble postnatal Purkinje cells in vivo by forming
dendritic branchlets (Figures 3A and 3B) through two stages
(Tabata et al., 2000). To establish an in vitro model of the pcd
Purkinje cell pathological process, we transduced wild-type
cerebellar cell cultures with lentiviral vector-based Nna1 shRNA
(Table S5) from 7 to 14 days in vitro (DIV), and found that Nna1
RNA interference (RNAi) significantly suppressed Purkinje cell
dendritic growth at 14 DIV (Figures 3C and 3D) and increased
Purkinje cell death at 21 DIV (Figure S3B). We also cotransduced
cerebellar cell cultures with both Nna1 shRNA and Lox shRNA
(Table S5), and found that Lox shRNA greatly rectified Nna1
RNAi-reduced Purkinje cell dendritic growth (Figures 3C and
3D), but did not prevent Nna1 RNAi-triggered Purkinje cell death
(Figure S3B). These results suggest that Lox plays a role in pcd
Purkinje cell dendritic development, but is less important in
pcd Purkinje cell death.
To verify the possible relationship between increased Lox and
abnormal dendritic development, we treated cerebellar cell
cultures with suramin, a Lox expression stimulator (Buchinger
et al., 2008), and found that suramin suppressed Purkinje cell
dendritic growth (Figures 3E and 3F). We then transduced(E) Western blot showed very low levels of Lox protein in P7, P10, P15, and P20
served as a loading control.
(F) Immunohistochemical images showed postnatal development of Purkinje cell
The increased Lox staining (green) in P20 pcdSid Purkinje cell bodies (Calb, red) ga
(Calb, red). Calb, calbindin staining. DAPI stained cell nuclei (blue). Scale bar rep
(G) Schematics summarizing the major pathological processes leading to pcdSid P
dark type of apoptosis, which finally resulted in loss of most Purkinje cell and secerebellar cell cultures with lentiviral vector-based Lox cDNA
(Figure S3C and Table S5) from 2 to 7 DIV (the early stage), or
from 7 to 14 DIV (the later stage), and found that Lox cDNA
significantly reduced Purkinje cell perisomatic sprouting at the
early stage (Figure S3D) and Purkinje cell dendritic arborization
at the later stage (Figures 3E and 3F; Figure S3E), which were
rectified by Lox shRNA (Figures 3E and 3F). The efficiency of
Lox cDNA or Lox shRNA transduction was confirmed by Lox
protein assay in either cultured cells or culture medium (Fig-
ure 3G). These results suggest that increased Lox expression
in cerebellar cell cultures may interfere with Purkinje cell
dendritic growth at both early and later stages.
We next set up cerebellar organotypic slice cultures (Li et al.,
2006a, 2006b) from P7 mouse pups (Figure S4A) to analyze later
stages of Purkinje cell dendritic growth (Figures 4A and 4B) and
viability (Figure S4B). We found that treatment with suramin or
Lox cDNA from 0 to 7 DIV (P7 + 7 DIV = 14 days) and from 10
to 14 DIV (P7 + 14 DIV = 21 days) greatly suppressed Purkinje
cell dendritic growth (Figures 4C and 4D; data not shown). These
effects on Purkinje cell dendrites could be rectified by Lox
shRNA (Figures 4C and 4D), and were coincident with our
finding that Lox upregulation in vivo was accompanied by under-
development of P20 pcd Purkinje cell dendrites (Figure 2F;
Figures S1I and S1K).
Verification of Lox cDNA Effects on Purkinje Cell
Dendritic Development In Vivo
Viral vectors carrying the L7 promoter are useful for selective
expression of a foreign gene in Purkinje cells in vivo, but this
promoter’s low transcriptional efficiency and large size limit its
value for transduction (Takayama et al., 2008). Lentiviral vectors
have a larger insert capacity, elicit no or minimal inflammatory
response, and integrate genes into target cell chromosomes,
leading to stable long-term expression (Hirai, 2008; Torashima
et al., 2006). To avoid an inhibitory effect on Purkinje cell
dendrites caused by a strong MSCV (murine stem cell virus)
promoter (Sawada et al., 2010), we prepared lentiviral vector-
based gene constructs carrying the weaker CMV (cytomegalo-
virus) promoter (Table S5). These constructs themselves did
not change Purkinje cell dendrite morphology in vivo (Figure 5E).
To study whether excess Lox affects postnatal development
of Purkinje cell dendrites in vivo, we injected Lox cDNA tagged
with eGFP, control eGFP cDNA, or control vehicle into the
cerebellar cortices of P7 wild-type mice (Figure S5A and
Table S5). As expected, the locally transduced Purkinje cells
displayed green fluorescence (Figure S5B), and Lox cDNA signif-
icantly suppressed development of Purkinje cell dendrites exam-
ined at P14 and P21 (Figures 5A–5E). However, this inhibitory
effect on dendritic development did not lead to the Purkinje
cell death (Figures S5C and S5D), characteristic of pcd mutantswild-type cerebella and an increased level in P20 pcdSid cerebellum. b-actin
dendrites in P7, P14, and P20 wt (upper) and pcdSid (lower) cerebellar cortices.
ve a net yellow color, and was concurrent with the reduced dendritic branching
resents 12 mm.
urkinje cells death. Nna1mutation triggered abnormal protein metabolism and
vere ataxia in pcdSid mutant mice.
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Figure 3. Purkinje Cell Dendritic Growth in Cerebellar Cell Cultures Transduced by Nna1 shRNA, Lox cDNA, and Lox shRNA
(A) Representative images of cultured Purkinje cells stained by calbindin (Calb, left) and traced with Neurolucida (right). The images were obtained by confocal
microscopy (633, oil objective) for dendrite tracing. Scale bar represents 15 mm.
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Figure 4. Quantification of Purkinje Cell
Dendritic Trees in Wild-Type and pcdSid
Cerebellar Slice Cultures
(A) Representative images of Purkinje cells in orga-
notypic slice cultures stained by calbindin (Calb,
upper) and traced with Neurolucida (lower).
Cultures were photographed by confocal micros-
copy (633, oil objective) for dendrite tracing. Scale
bar represents 20 mm.
(B) Representative schematic Sholl diagram
showed parameters as in Figure 3B.
(C) Quantitative analyses showed total node or
end number and total dendrite length per field at
day 14 (P7 + 7 DIV) in wild-type (left and middle)
and pcdSid (right) cerebellar slice cultures after
various treatments. Control, control cDNA or
shRNA; Lox, Lox cDNA; Lv, lentiviral vector. BCS
and BAPN are Lox enzymatic inhibitors. Values
represented means ± SD; n = 4–8; compared to
control: *p < 0.05 or **p < 0.01.
(D) Sholl analysis showed total length of Purkinje
cell dendrites within each concentric circle
(0–10 mm, 10–20 mm, . 90–100 mm) at day 14
(P7 + 7 DIV) in wild-type (left and middle) and
pcdSid (right) cerebellar slice cultures after various
treatments. Each curve area represented an
average value of total Purkinje cell dendrite length
in each treatment. Peak values positively corre-
lated with dendritic density.
Neuron
Control of PC Dendrite Genesis by Lox and RelAat P21–P28. Lox cDNAandcontrol cDNAalso transduced a small
number of granule cell precursors, stellate or basket interneu-
rons, and Bergmann glial cells, but these cells did not show(B) Representative schematic Sholl diagram showed parameters of node (green dot), end (orange dot) and d
dendritic trees. The distance between adjacent concentric circles was 10 mm.
(C and E) Quantitative analyses showed total node or end number and total dendrite length per Purkinje cel
control cDNA or shRNA; Lox, Lox cDNA; Lv, lentiviral vector. Values represented means ± SD; n = 6–10; co
(D and F) Sholl analyses showed total length of Purkinje cell dendrites within each concentric circle (0–10 mm, 1
cultures. Each curve area represented an average value of total Purkinje cell dendrite length in each treatme
density.
(G) Western blot results were quantified with Quality I software, and showed Lox protein levels at 14 DIV in bo
Lox cDNA; 3: Lox cDNA+Lox shRNA; 4: Nna1 shRNA; 5: Nna1 shRNA+Lox shRNA. n = 3.
Neuron 68, 45–6obvious changes in morphology (Figures
S5E–S5G). These in vivo results thus
confirm our in vitro findings that excess
Lox interferes selectively with Purkinje
cell dendritic arborization during post-
natal development.
Inhibitory Effect of Excess Lox
on Purkinje Cell Dendrites Is
Cell-Autonomous and Independent
of Lox Enzymatic Activity
To test whether the effect of excess Lox
on Purkinje cell dendritic growth is cell-
autonomous, we transduced P0 enriched
Purkinje cell cultures with Lox cDNA, and
then added either P7 enriched granule
cells or 7 DIV conditioned medium fromcerebellar cell cultures into the transduced Purkinje cell cultures.
We found that Lox cDNA did suppress dendritic growth of the
enriched Purkinje cells, and this was not prevented by additionendrite (blue dot) for quantification of Purkinje cell
l (PC) at 14 DIV in cerebellar cell cultures. Control,
mpared to control: *p < 0.05 or **p < 0.01.
0–20 mm,. 90–100 mm) at 14 DIV in cerebellar cell
nt. Peak values positively correlated with dendritic
th cultured cells and culture medium. 1: Control; 2:
0, October 7, 2010 ª2010 Elsevier Inc. 51
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Figure 5. Effects of Lentiviral Vector-Based Lox cDNA Transduction on Purkinje Cell Dendritic Development In Vivo
(A) Representative fields of calbindin (Calb)-stained (upper) and Neurolucida- traced (lower) Purkinje cells. Serial stained cerebellar sections (40 mm thick) were
photographed by confocal microscopy (633, oil objective) for dendrite tracing. Scale bar represents 20 mm.
(B) Representative schematic Sholl diagram showed parameters as in Figure 3B.
(C) Quantitative analyses showed total node or end number and total dendrite length per field in P14 (left) and P21 (right) cerebellar cortices. Control, control
cDNA; Lox, Lox cDNA; GFP, GFP cDNA. Values represented means ± SD; n = 4–6; compared to control: *p < 0.05 or **p < 0.01.
(D) Sholl analysis showed total length of Purkinje cell dendrites within each concentric circle (0–10 mm, 10–20 mm,. 110–120 mm) in P14 (upper) and P21 (lower)
cerebellar cortices. Each curve area represented an average value of total Purkinje cell dendrite length in each treatment. Peak values positively correlated with
dendritic density.
(E) No cDNA-, GFP cDNA-, and Lox-GFP cDNA-transduced Purkinje cells (GFP tag, green) were stained with calbindin (Calb, red) for cell bodies and dendrites. GFP
itself alone did not affect Purkinje cell dendrites, but Lox overexpression suppressed obviously Purkinje cell dendritic development. Scale bar represents 20 mm.
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Control of PC Dendrite Genesis by Lox and RelAof enriched granule cells or conditioned medium (Figures 6A
and 6B), suggesting that overexpressed Lox may affect Purkinje
cell dendritic growth in a cell-autonomous manner, independent
of neighboring granule cell actions and factors in the conditioned
medium.
To check whether the inhibitory effect of excess Lox on
Purkinje cell dendritic growth is related to Lox enzymatic activity,
we treated cerebellar cell cultures with various Lox enzyme
regulators. We verified that copper (a Lox enzymatic activator)
and Lox cDNA increased Lox enzymatic activities (Figure 6C),
whereas bathocuproinedisulfonate (BCS, an inhibitor of extra-
cellular Lox activity) and b-aminopropionitrile fumarate (BAPN,
an inhibitor of both extracellular and intracellular Lox activity)
(Erler et al., 2006) not only inhibited Lox enzymatic activities,
but also restored Lox cDNA-increased enzymatic activities
(Figure 6C). However, neither copper nor BCS and BAPN
changed the morphology of Purkinje cell dendritic trees, or pre-
vented Lox cDNA-suppressed Purkinje cell dendritic growth
(Figures 6D and 6E). These findings were also confirmed in
wild-type cerebellar slice cultures (Figures 4C and 4D). Thus,
we found no significant correlation between Lox enzymatic
activity and Purkinje cell dendritic growth (Figure 6F).
Furthermore, we treated pcdSid (Figures 4C and 4D) and pcd2J
(Figures S4C and S4D) cerebellar slice cultures with BCS, BAPN,
or Lox shRNA, and found that only Lox RNAi prevented Nna1
mutation-triggered abnormal Purkinje cell dendritic growth at
the later stage. Nonetheless, Lox cDNA did not significantly
change Purkinje cell survival in wild-type control slices (Figures
S4E and S4F), and Lox RNAi or enzymatic inhibitors did not
rectify Purkinje cell loss in pcdSid slice cultures (Figures S4E
and S4F). Survival of granule cells (Figure S4G) and glial cells
(Figure S4H) did not differ among the various treatments. These
slice culture experiments verify our findings with the cerebellar
cell cultures, i.e., Lox RNA knockdown, rather than Lox enzy-
matic inhibition, can rectifyNna1mutation- or Nna1 shRNA-sup-
pressed Purkinje cell dendritic development, but this does not
prevent pcd Purkinje cell death.
Excess Lox Propeptide in Purkinje Cell Nuclei
Is Responsible for Purkinje Cell Dendritic
Underdevelopment
We next looked more deeply into the basis for the effect on
Purkinje cell dendritic development by analyzing Lox propeptide.
Lox is synthesized as a 50 kDa precursor, secreted into the
extracellular matrix, and subsequently catabolized to a 30 kDa
mature enzyme fragment from the C-terminal moiety and an
18 kDa propeptide fragment without enzymatic activity from
the N-terminal region (Lucero and Kagan, 2006). Extracellular
Lox propeptide is arginine-rich, and readily taken up by cells
due to its unusually high isoelectric point of 12.5 (Palamakum-
bura et al., 2004). We transduced cerebellar cell and slice
cultures with lentiviral vector-based Lox propeptide cDNA
(Table S5), whose efficiency was confirmed by Lox propeptide
protein assay (Figure 6G). We found that Lox propeptide cDNA
by itself did not change Lox enzymatic activity (Figure 6C), but
like Lox cDNA, did suppress Purkinje cell dendritic growth in
both cerebellar cell (Figures 6D and 6E) and slice (Figures 4C
and 4D) cultures. These results confirm that excess Lox or Loxpropeptide suppresses Purkinje cell dendritic growth by mecha-
nisms unrelated to Lox enzymatic activity.
Because Lox and Lox propeptide are known to display
stage-dependent distribution in various organelles of osteo-
blasts (Guo et al., 2007), we measured Lox and Lox propeptide
distribution in Lox cDNA- or Lox propeptide cDNA-transduced
Purkinje cells, where dendritic growth was suppressed. The
two primary antibodies we used were an antibody against the
C-terminal segment of Lox for detecting entire Lox or Lox
enzyme, and a Lox propeptide antibody against the N-terminal
segment for detecting entire Lox or Lox propeptide. We found
that no signals could be detected by either antibody in control
Purkinje cells (Figure 6H). When Purkinje cells were transduced
by Lox cDNA, the signals were detected in nuclei, cell bodies
and dendrites by the Lox enzyme antibody, and were detected
in nuclei and cell bodies by the Lox propeptide antibody (Fig-
ure 6H). When cells were transduced by Lox propeptide cDNA,
the signals were detected predominantly in nuclei by only the
Lox propeptide antibody (Figure 6H). These findings indicate
that excess Lox propeptide protein is concentrated in Purkinje
cell nuclei, a site for gene transcriptional regulation.
Nna1 shRNA or Lox Propeptide cDNA Suppresses
Purkinje Cell Dendritic Growth via Reduced RelA
Lox and Lox propeptide were reported to suppress cancer cell
transformation (Palamakumbura et al., 2004) or vascular smooth
muscle cell proliferation (Hurtado et al., 2008) via inhibition of
NF-kB signaling. Because NF-kB regulates neuronal process
outgrowth (Gutierrez et al., 2005) and synaptic function (Meffert
et al., 2003), we hypothesized that the inhibitory effect of excess
Lox propeptide on Purkinje cell dendrites might be mediated by
abnormal NF-kB signaling. Our microarray and qPCR data
showed that RelA, a major member of the NF-kB family, was
significantly downregulated in LCM-isolated pcdSid Purkinje
cells (Figures 2A and 2B). We also measured three components
(Table S3) of the NF-kB family in Nna1 shRNA-, Lox cDNA-, or
Lox propeptide cDNA-transduced cerebellar cell cultures, and
found that mRNA and protein levels of NF-kB RelA were greatly
decreased, whereas NF-kB p50 and IkBa were not significantly
changed (Figures 7A and 7B). Importantly, we observed that
Lox RNAi could rectify Nna1 shRNA-induced NF-kB RelA
reduction (Figures 7A and 7B).
We next checked effects of diverse Nna1 and RelA treatments
on Lox levels, and found that Nna1 shRNA, rather than RelA
cDNA or shRNA, significantly increased Lox mRNA levels in
cultured Purkinje cells (Figure 7C). Also, neither RelA cDNA nor
shRNA rectified the Nna1 shRNA-induced Lox mRNA upregula-
tion (Figure 7C). The efficiency of RelA cDNA or shRNA transduc-
tion was verified by RelA protein assay (Figure 7D). Furthermore,
both Lox andRelAmanipulation did not changeNna1 expression
(data not shown).
RelA contains a transactivation domain that is required for
transport of the active NF-kB complex into cell nuclei. In
contrast, p50 lacks this domain and must form heterodimers
with RelA to translocate into cell nuclei. We observed by immu-
nohistochemistry and confocal microscopy that intranuclear
RelA was much lower in P20 pcdSid mutant Purkinje cells than
in wild-type controls in vivo (Figure 7E). With DNA-binding ELISANeuron 68, 45–60, October 7, 2010 ª2010 Elsevier Inc. 53
Figure 6. Roles of Lox Enzymatic Regulators and Intranuclear Lox Propeptide (without Enzymatic Activity) in Cerebellar Purkinje Cell
Cultures
(A) Total relative number of nodes or ends, and total relative dendrite length per Purkinje cell at 14 DIV in enriched Purkinje cell (PC) cultures. Control, control cDNA
or shRNA; Lox, Lox cDNA; Lv, lentiviral vector; GC, enriched granule cells; CM, conditioned medium from cerebellar mixed cell cultures. Values represented
means ± SD; n = 6–8; compared to control: *p < 0.05 or **p < 0.01.
(B) Representative images of cultured Purkinje cells stained by calbindin (Calb, red) and Lox (green). Addition of granule cells (GC) neither affected Purkinje
cell dendrites (left), nor rectified Lox cDNA-suppressed Purkinje cell dendritic growth (right). DAPI stained mainly granule cell nuclei (blue). Scale bar represents
20 mm.
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Control of PC Dendrite Genesis by Lox and RelAassays wemeasured NF-kB activation in Purkinje cell nuclei, and
found that RelA overexpression increased only RelA transactiva-
tion (Figure 7F), but not p50 transactivation (Figure 7G), whereas
RelA downregulation by Nna1 shRNA, Lox cDNA, Lox propep-
tide cDNA, or RelA shRNA significantly inhibited both RelA
(Figure 7F) and p50 (Figure 7G) transactivation.
We found further that RelA downregulation suppressed
Purkinje cell dendritic growth (Figures 7H and 7I). To detect
whether abnormal RelA mediated excess Lox-suppressed
dendritic growth of Purkinje cells, we treated Lox cDNA-trans-
duced cerebellar cell cultures with an NF-kB activator, tumor
necrosis factor-a (Royuela et al., 2008), and found that this factor
significantly protected Purkinje cell dendritic trees (data not
shown). In addition, although RelA cDNA by itself did not
obviously alter Purkinje cell dendritic morphology (Figures 7H
and 7I), it did rectify Nna1 shRNA- or Lox propeptide cDNA-
suppressed Purkinje cell dendritic growth (Figures 3C, 3D, 6D,
6E, 7H, and 7I), suggesting that NF-kB RelA downregulation
mediated the inhibitory effects of Nna1 RNAi or Lox propeptide
overexpression on dendritic growth of developing Purkinje cells.
Abnormal NF-kB Signaling Alters MAPs Controlling
Purkinje Cell Dendritic Growth
Microtubules composed of tubulin subunits are major cytoskel-
etal components running longitudinally in neuronal processes,
and MAPs bind to tubulin subunits to control microtubule
stability. MAP-microtubule binding is regulated by microtubule
affinity regulating kinase (MARK) with phosphorylation detaching
MAP from microtubules. We detected a significant downregula-
tion of MAP1B mRNA and MAP2 mRNA, and an upregulation of
MARK3 mRNA in LCM-isolated Purkinje cells of P20 pcdSid
mutants (Figure S6A). Both MAP1B and MAP2 are expressed
predominantly in Purkinje cell dendrites, relative to Purkinje cell
axons (Chauhan and Siegel, 1997). The double knockout of
MAP1B andMAP2 has synergistic effects on neuronal migration,
dendritic growth and microtubule organization (Teng et al.,
2001). We examined spatial and temporal distribution of
microtubule and MAP proteins in postnatal cerebella by immu-
nohistochemistry, and found obvious decreases of MAP1B,
MAP2, and tubulin bIII in the molecular layer of P20 pcdSid cere-
bellar cortices (Figure 8A). We next measuredMAP1B andMAP2
in cerebellar cell cultures that had been transduced by Nna1
shRNA, Lox cDNA, Lox propeptide cDNA, or RelA shRNA, and
found that these lentiviral vector-mediated transductions in-
hibited MAP1B and MAP2 levels in Purkinje cell dendritic
branches (Figure 8B). Furthermore, we found by quantitative
analysis that Lox shRNA or RelA cDNA rectified Nna1 RNAi-
reduced MAP1B, whereas RelA cDNA rectified Lox or Lox(C) Lox enzymatic activities at 14 DIV in cerebellar cell cultures. BCS and BAPN w
(D) Quantitative analyses showed total node or end number and total dendrite le
(E) Sholl analyses showed total length of PC dendrites within each concentric circ
curve area represented an average value of total PC dendrite length in each trea
(F) No significant correlation between Lox enzymatic activity and PC dendrite len
(G) Western blot results were quantified with Quality I software, and showed Lox
cDNA; 3: Lox cDNA+Lox shRNA; 4: Nna1 shRNA; 5: Nna1 shRNA+Lox shRNA; 6
(H) Immunostaining showed intracellular or intranuclear localization of Lox and L
cultures. The Lox antibody (Lox Ab, green) against C-terminal of Lox could detect e
against N-terminal of Lox could detect entire Lox and/or Lox-p (lower). Scale bapropeptide cDNA-reduced MAP1B (Figure S6B). These results
indicate that changes in microtubule and MAP levels are associ-
ated with Purkinje cell dendritic underdevelopment in postnatal
pcd cerebellar cortices in vivo and in Nna1 shRNA-treated
cerebellar cell cultures.
To establish a causal relationship between abnormal MAP
levels and Purkinje cell dendritic underdevelopment, we trans-
duced cerebellar cell cultures with MAP shRNA and cDNA.
Neither MAP1B shRNA nor MAP2 shRNA alone changed Pur-
kinje cell dendritic trees, but a joint application of the two
shRNAs significantly suppressed Purkinje cell dendritic growth
(Figures 8C and 8D). In contrast, either MAP1B cDNA or MAP2
cDNA individually rectified RelA shRNA-suppressed Purkinje
cell dendritic growth (Figures 8C and 8D). These data are consis-
tent with a previous report (Teng et al., 2001), suggesting a func-
tional redundancy betweenMAP1B andMAP2, and a synergistic
effect of their double deficiency on Purkinje cell dendritic growth.
Our findings disclose that abnormal MAP1B and MAP2 mediate
the underdevelopment of Purkinje cell dendrites triggered by
Nna1 mutation, Lox-propeptide cDNA, or RelA shRNA.
DISCUSSION
In this study, we characterize a pcd mutant allele, pcdSid that
shows postnatal Purkinje cell death and severe ataxia due to
the deletion of Nna1 exon 7. We correlate increased Lox with
underdevelopment of pcdSid Purkinje cell dendrites before
neuronal death, and dissect a molecular pathway (Figure 8E) in
which the Nna1 mutation upregulates Lox and increases Lox
propeptide in Purkinje cell nuclei. The excess Lox propeptide
inhibits NF-kB RelA signaling and MAP roles in Purkinje cell
dendritic growth. We formulate this molecular pathway based
on several findings. First, the Nna1 mutation increases Lox,
reduces RelA andMAPs, and suppresses Purkinje cells dendritic
growth in vivo and in vitro, supporting that Lox, RelA, and MAPs
are downstream from Nna1. Second, although excess Lox
reduces RelA, manipulation of RelA does not alter Lox levels,
suggesting that RelA is downstream from Lox. Third, RelA
shRNA alters MAPs and suppresses Purkinje cell dendritic
growth, whereas MAP cDNA blocks the inhibitory effects of
RelA shRNA on Purkinje cell dendritic growth, an indication
that MAPs are downstream from NF-kB RelA signaling.
The pcd mouse model (Wang and Morgan, 2007), one of
the first among the presently identified 50 mutation-induced
cerebellar ataxias, includes a group of autosomal recessive
mutations in the Nna1 gene, pcd1J-8J,Babe,Btlr,Tg. We present
two previously undescribed Nna1 mutations: a deletion of the
entire exon 7 in pcdSid, and a six-nucleotide insertion betweenere Lox enzymatic inhibitors. Lox propeptide, Lox propeptide cDNA. n = 4–6.
ngth per PC at 14 DIV in cerebellar cell cultures. n = 6–10.
le (0–10 mm, 10–20 mm,. 90–100 mm) at 14 DIV in cerebellar cell cultures. Each
tment. Peak values positively correlated with dendritic density.
gth at 14 DIV in cerebellar cell cultures. R2 = 0.285 (p > 0.05).
propeptide (Lox-p) levels at 14 DIV in cerebellar cell cultures. 1: Control; 2: Lox
: Lox propeptide cDNA. n = 4–6.
ox-p in Lox cDNA- or Lox-p cDNA-transduced Purkinje cells of cerebellar cell
ntire Lox and/or Lox enzyme (upper), and the Lox-p antibody (Lox-p Ab, green)
r represents 10 mm.
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Figure 7. Roles of Reduced NF-kB RelA in
Mutant Nna1- and Excess Lox Propeptide-
Suppressed Purkinje Cell Dendritic Growth
(A) qPCR results showed mRNA levels of RelA,
p50 and IkBa in the NF-kB family at 14 DIV in cere-
bellar cell cultures. Control, control cDNA or
shRNA; Lox, Lox cDNA; Lox propeptide, Lox pro-
peptide cDNA; Lv, lentiviral vector. Gapdh served
as an internal control. Values represented means
± SD; n = 5–6; compared to control: *p < 0.05 or
**p < 0.01.
(B) Western blot results were quantified with
Quality I software, and showed RelA protein levels
at 14 DIV in cerebellar cell cultures. b-actin served
as a loading control. 1: Control; 2: Lox cDNA; 3:
Lox cDNA+Lox shRNA; 4: Nna1 shRNA; 5: Nna1
shRNA+Lox shRNA; 6: Lox propeptide cDNA.
n = 3.
(C) qPCR results showed Lox mRNA levels at 14
DIV in cerebellar cell cultures. RelA, RelA cDNA.
n = 5.
(D) Western blot results were quantified with
Quality I software, and showed RelA protein levels
at 14 DIV in cerebellar cell cultures transduced by
RelA cDNA or shRNA. n = 3.
(E) Immunohistochemical images showed RelA
protein distribution in Purkinje cells of P20 wild-
type (wt; upper) and pcdSid (lower) cerebellar
cortices in vivo. The decreased RelA staining
(green) in pcdSid Purkinje cell bodies (Calb, red)
was concurrent with the reduced dendritic
branching (Calb, red). Calb, calbindin staining.
Scale bar represents 12 mm.
(F and G) ELISA assay detected NF-kB RelA (F) or
p50 (G) transactivation at 14 DIV in nuclear
extracts from cultured Purkinje cells. n = 4.
(H) Quantitative analyses showed total node or
end number and total dendrite length per Purkinje
cell (PC) at 14 DIV in cerebellar cell cultures trans-
duced by RelA cDNA or shRNA. Lox-p, Lox pro-
peptide cDNA. n = 5–6.
(I) Sholl analysis showed total length of Purkinje
cell dendrites within each concentric circle (0–10
mm, 10–20 mm, . 90–100 mm) at 14 DIV in cere-
bellar cell cultures transduced by RelA cDNA or
shRNA. Each curve area represented an average
value of total Purkinje cell dendrite length in each
treatment. Peak values positively correlated with
dendritic density.
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Control of PC Dendrite Genesis by Lox and RelAexon 6 and exon 7 in pcd4J, further evidence that Nna1 is a
vulnerable gene. We also report that P20 pcdSid mutants feature
Purkinje cell dendritic underdevelopment just before the onset of
massive Purkinje cell loss.
Global gene profiling in entire cerebellum does not provide
the spatial resolution to address malfunction of Purkinje cells
selectively, and conventional microarray strategies may not
accurately analyze a very little RNA (<1 ng) from single cells.
To gain a more comprehensive view of the molecular relation-
ships involved in pcdSid Purkinje cell pathogenesis, we develop56 Neuron 68, 45–60, October 7, 2010 ª2010 Elsevier Inc.an advanced strategy of pico RNA amplification and cDNA
purification followed by microarray to measure the global gene
profiling in LCM-isolated P20 wild-type and pcdSid Purkinje cells
and granule cells. At P20, although molecular pathogenic
changes have begun, pcdSid Purkinje cells are still surviving.
We not only identify upregulated candidate molecules such as
Calr3, Lox, and Bim for abnormal protein synthesis, dendritic
underdevelopment, and apoptosis, respectively, but also
disclose additional potential markers for Purkinje cells and
granule cells (Table S2).
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Control of PC Dendrite Genesis by Lox and RelALox has been widely described to havemultiple roles in forma-
tion and repair of extracellular matrix (Lucero and Kagan, 2006),
in development of cardiac, pulmonary and cutaneous tissues
(Ma¨ki, 2009; Rodrı´guez et al., 2008; Szauter et al., 2005), and
in tumor progression and metastasis (Erler et al., 2006; Payne
et al., 2007). Although Lox levels are increased in selected types
of diseased brains in rodents and humans (Gilad et al., 2001,
2005; Li et al., 2004), its role in the CNS is unknown. Here, we
describe a pathological role of excess Lox in the CNS, particu-
larly in Purkinje cell dendritic development. We show that the
remarkably upregulated Lox levels in pcdSid Purkinje cells are
concurrent with pcdSid Purkinje cell dendritic underdevelop-
ment, and that excess Lox negatively regulates dendritic
arborization of developing Purkinje cells in cerebellar cell or slice
cultures and in the cerebellar cortex in vivo.
Most of the previously reported effects of Lox involve its
copper-utilizing enzymatic activity, particularly on extracellular
collagen and elastin. In contrast, nonenzymatic Lox propeptide
suppresses prostate (Palamakumbura et al., 2009), breast (Min
et al., 2007), lung, and pancreatic (Wu et al., 2007) cancer cells.
We observe that Purkinje cell dendritic growth is suppressed by
excess Lox via mechanisms independent of its enzymatic
activity, for Lox enzymatic inhibitors do not rectify actions of
Lox overexpression, and Lox propeptide (lacking Lox enzymatic
activity) has a similar action to enzymatic Lox. Thus, our study
prompts a new research direction on this important molecule.
Lox propeptide inhibition of cancer cell transformation and
tumor formation is associated with NF-kB and other signaling
pathways (Min et al., 2007; Palamakumbura et al., 2009; Wu
et al., 2007). In the CNS, nuclear translocation and gene activa-
tion of transcription factor NF-kB regulate neuronal processes
(Gutierrez et al., 2005) and synapses (Meffert et al., 2003). We
find that excess Lox propeptide suppresses Purkinje cell
dendritic growth also via the NF-kB signaling pathway. RelA,
a major member of the NF-kB family and a positive regulator of
neuronal process growth, shows reduced expression and less
nuclear translocation in pcdSid Purkinje cells in vivo. A role for
RelA in this dendritic development pathway is also consistent
with the observed downregulation of RelA expression and inhibi-
tion of RelA transactivation by Nna1 shRNA or Lox propeptide
cDNA in cerebellar cell cultures. Exogenous expression of RelA
can block the suppression of Purkinje cell dendritic growth due
to excess Lox propeptide. Our data further show that RelA
knockdown alters MAP1B and MAP2, two key regulators of
Purkinje cell dendritic development.
MAPs promote assembly of tubulin, bind and stabilize
microtubules, and form cross-bridge structures between micro-
tubules. MAP1B and MAP2 are among the most abundant
neuronal MAPs, and play important roles in neuronal morpho-
genesis. We confirm that MAP1B and MAP2 are expressed
predominantly in Purkinje cell dendrites, relative to Purkinje cell
axons (Chauhan and Siegel, 1997). These two MAPs show
functional redundancy, because mice with double knockouts,
but not with either single knockout, show inhibited dendritic
growth (Teng et al., 2001).We also establish a causal relationship
between MAP1B/MAP2 and Purkinje cell dendritic growth by
MAP knockdown and overexpression. Thus, our study describes
a molecular pathway composed of mutant Nna1, excess Loxpropeptide, reduced NF-kB RelA, and altered MAP1B and
MAP2, which suppresses dendritic growth in developing Pur-
kinje cells. This unusual pathway may be relevant to other
cerebellar diseases that primarily affect Purkinje cells.
EXPERIMENTAL PROCEDURES
Animals
We maintained pcdSid mutants in a congenic C57BL/6J strain, and obtained
pcd2J, pcd3J, and pcd4J mutants from The Jackson Laboratory. Progeny
were generated by either heterozygote x heterozygote crosses, or homozy-
gous female x heterozygous male crosses. The pcd genotyping was carried
out withNna1 genome DNA PCR for pcd2J and pcd3J, Nna1 cDNA sequencing
for pcd4J, and Nna1 mRNA RT-PCR for pcdSid. Adult homozygotes were also
identified in segregating litters by the obvious ataxia. The use of animals in the
present study was in accordance with NIH-approved institutional guidelines
established by Harvard Medical School. All efforts were made to minimize
the number of animals used and their suffering.
LCM and Microarray Analysis
Purified Purkinje and granule cells were isolated from fresh cerebellar tissues
of P20 pcdSid and wild-type littermates by an ArcturusXT LCM instrument
(Molecular Devices). PicoPure RNA extraction kit was used to extract
total RNA from the cells. WT-Ovation pico RNA amplification kit and
FL-Ovation cDNA biotin module V2 kit (NuGEN) were used in succession to
prepare enough qualified cDNA for microarray (Affymetrix mouse genome
430 2.0 array).
qPCR and Nucleotide Sequencing
SYBR Green I-based qPCR was carried out with a DNA engine opticon
continuous fluorescence detection system. For normalization of each sample,
GAPDH primers were used to measure the amount of GAPDH cDNA. The data
were presented as ratios of measured gene/GAPDH. Some PCR products
were verified with 1% agarose gel.
Nucleotide sequence of Nna1 cDNA was analyzed at the BIDMC
Sequencing Facility. Samples were electrophoresed, detected, and analyzed
on a PE/ABI 377 DNA sequencer. Sequence data were analyzed with Gene
Runner software and the BLAST program.
Cerebellar Cell and Slice Culture
Mixed cerebellar cells or enriched Purkinje cells from P0 C57BL/6J mouse
pups were cultured in serum-free medium for 7–21 DIV; and cerebellar
organotypic slices from P7 mouse pups were cultured in serum-containing
medium for 7–14 DIV. The cultures were treated with various factors at
designated times. Specific antibodies were used to assess Purkinje cell
survival, dendritic branchlets, and other cerebellar cells.
Lentiviral Vector-Based cDNA or shRNA Transduction
Omicslink expression construct (GeneCopeia), pReceiver-Lv08 with CMV
promoter, was used for packaging, transduction, and stable integration of
Lox, Lox-propeptide, RelA, MAP1B, or MAP2 cDNA into genomic DNA of
cerebellar cells. Mission lentiviral transduction particles (Sigma) containing
pLKO.1-puro expression construct with U6 promoter were used to transduce
Nna1, Lox, RelA, MAP1B, or MAP2 shRNA into cerebellar cells.
Quantification and Statistic Analysis
Number and proportion of the specific (calbindin, Lox, or others) staining
positive- and negative-cells were counted from cerebellar cell and slice
cultures in vitro, or stereologically quantified from a series of representative
sequentially-cut cerebellar sagittal sections (40 mm) in vivo. Single Purkinje
cells in cerebellar cell cultures and grouped Purkinje cells in cerebellar slice
cultures or the cerebellar cortices (lobules V–VIII) in vivo were randomly
selected and imaged by confocal microscopy (Zeiss Axiovert 100M) with a
633 oil objective under optimal conditions (laser power, background, and
signal threshold). Z series images for each sample acquired by 1 mm optical
sectioning were projected onto a 2D image file, and the complete dendriticNeuron 68, 45–60, October 7, 2010 ª2010 Elsevier Inc. 57
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Control of PC Dendrite Genesis by Lox and RelAarborization of Purkinje cells was traced and analyzed with Neurolucida
software (MicroBrightField Bioscience). The parameters for dendrite quantifi-
cation included node number, end number, dendrite length, and dendrite
distribution (Sholl analysis). The data were presented as the parameter per
Purkinje cell in cell cultures (without dendritic tree overlapping between
adjacent cells), or as the parameter per field in slice cultures or the cerebellum
in vivo (with dendritic tree overlapping between adjacent cells). ImageJ
software (NIH) was used to quantify immunofluorescence staining images.
Quantity I software was used for the quantitative analyses of cDNA and protein
bands on gel or film. Comparison between groups, either paired or unpaired as
required, was carried out with (1) analysis of variance (ANOVA) and the
Student’s t or t0 test (according to results of the homoscedasticity analysis)
for the measurement data; (2) the c2 test for enumeration data; (3) the linear
or nonlinear regression analysis for correlation data; and (4) the Ridit analysis
for ranked data. Results were presented as means ± standard deviation (SD),
and differences were considered as significant at p < 0.05 or very significant
at p < 0.01.
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